Patient enrolment
A total of 38 patients were screened for enrolment between March 2018 and March 2019, and 36 patients were ultimately included. Four patients who did not meet the primary efficacy endpoints and two patients who withdrew their consent were excluded from the full-analysis set (FAS) (Fig. Flowchart of patient enrolment. AS, autologous serum; PRP, platelet-rich plasma.Baseline demographics in the per-protocol set.Age, years(mean ± SD)Corneal staining score(mean ± SD)Conjunctival staining score(mean ± SD)Schirmer’s test I, mm(mean ± SD)Tear break-up time, s(mean ± SD)CDVA logMAR(mean ± SD)OSDI score(mean ± SD)SD, standard deviation; CDVA, corrected distance visual acuity; logMAR, logarithm of the minimum angle of resolution; OSDI, ocular surface disease index.